"Sylvester Comprehensive Cancer Center is the only university-based comprehensive cancer center and only NCI-designated cancer center in the region. With more treatment options and more clinical trials than most hospitals in the southeastern United States, Sylvester is advancing cancer care in the region and beyond — all in pursuit of your cure. Teams of physicians and scientists work together to move discoveries from Sylvester's labs to patients and out into the community. As the home to South Florida's only Phase 1 Clinical Trials program, Sylvester offers novel treatments and hope to patients with rare forms of cancer."

During the past decade, UM Sylvester Comprehensive Cancer Center at Kendall conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 5 clinical trials were completed, i.e. on average, 13.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UM Sylvester Comprehensive Cancer Center at Kendall" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UM Sylvester Comprehensive Cancer Center at Kendall" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "UM Sylvester Comprehensive Cancer Center at Kendall" are "Clinical Stage IV Cutaneous Melanoma AJCC v8" (6 trials), "Clinical Stage III Cutaneous Melanoma AJCC v8" (4 trials), "Unresectable Melanoma" (4 trials), "Invasive Breast Carcinoma" (3 trials) and "Metastatic Melanoma" (3 trials). Many other conditions were trialed in "UM Sylvester Comprehensive Cancer Center at Kendall" in a lesser frequency.

Most popular intervention types in "UM Sylvester Comprehensive Cancer Center at Kendall" are "Drug" (33 trials), "Biological" (24 trials), "Other" (24 trials), "Procedure" (22 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (13 trials), "Computed Tomography" (13 trials), "Nivolumab" (13 trials), "Laboratory Biomarker Analysis" (10 trials) and "Quality-of-Life Assessment" (10 trials). Other intervention names were less common.

The vast majority of trials in "UM Sylvester Comprehensive Cancer Center at Kendall" are 39 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UM Sylvester Comprehensive Cancer Center at Kendall". undefined are not yet recruiting, 18 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UM Sylvester Comprehensive Cancer Center at Kendall, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UM Sylvester Comprehensive Cancer Center at Kendall, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".